Unlock the potential of your CRISPR-based therapies with Aldevron's comprehensive support. Our latest brochure details how we can enhance your projects, regardless of your delivery method. Explore the possibilities today!
Aldevron
Biotechnology Research
Fargo, North Dakota 15,927 followers
The basis for breakthroughs
About us
Aldevron is proud to be part of Danaher. Danaher’s science and technology leadership puts Aldevron’s solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher’s other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.
- Website
-
http://www.aldevron.com
External link for Aldevron
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Fargo, North Dakota
- Type
- Privately Held
- Founded
- 1998
- Specialties
- Plasmid DNA, Messenger RNA (mRNA), Recombinant Proteins, CRISPR/Cas9, cGMP, GMP-Source, Gene Therapy, Cell Therapy, Vaccine Development, and Gene Editing
Locations
-
Primary
4055 41st Ave S
Fargo, North Dakota 58104, US
-
5602 Research Park Blvd
Suite 112
Madison, Wisconsin 53719, US
-
3100 University Dr S
Fargo, North Dakota 58103, US
Employees at Aldevron
Updates
-
We look forward to meeting you!
Business Development Manager, Cell & Gene Therapy | Benelux, France & Denmark | pDNA, mRNA, Protein services
Exciting news. We are organizing Aldevron's very first Lunch & Learn event in France at the Evry Génocentre on Thursday 12 Sept. Hear from our speakers #MaartenWalmagh & #TimTraynor how Aldevron can help unlocking the Future of Cell and Gene Therapy. Coffee & Lunch will be provided. Register now to secure your seat via below link, we are looking forward to connecting at this fun morning event. https://lnkd.in/e_rZ-qNC
-
-
As we kick off #SickleCell Awareness month, we recognize the approximately 100,000 individuals in the U.S. living with this chronic condition. Sickle cell disease causes severe and unpredictable pain, intense fatigue, frequent infections and more. Last September, Tom Foti Vice President/GM of Aldevron’s Protein Business Unit, spoke with James Griffin, a sickle cell patient and author of the book Breaking Silence: Living With Sickle Cell Anemia. You can read more about James and his experience with sickle cell in our blog post: https://ald.bio/3yZGNck. Just months after this conversation, the FDA made a groundbreaking decision to approve two #genetherapy treatments for sickle cell disease. While the future of sickle cell disease treatment is promising, we still have a long way to go to make these therapies accessible to all who need them. This month (and beyond!), let’s recognize the strength of these patients and emphasize the importance of helping them access innovative, life-changing treatments. #SickleCellAwareness #AdvancingEveryDay
-
ICYMI Removing impurities and increasing production efficiency is critical to streamlining the manufacturing process for mRNA drug product. As Aldevron experts discuss in our webinar, Streamlining the Path from Discovery to Patient: Simpler RNA Manufacturing, there are several considerations in the process, and multiple means of accomplishing those goals. https://ald.bio/3YYXGP7
Unlocking Efficiency for mRNA
aldevron.com
-
At Aldevron, the safety and well-being of our team are top priorities. During Safe + Sound Week earlier this month, we put our employees’ safety knowledge and commitment to the test! Paramedics and nurses presented to us on how to stop the bleed (lots of parents attended that class!), experts showed us how to be comfortable at our work stations with Ergonomics 101 for the Office Worker, and we completed a training on de-escalation techniques and pre-attack indicators. Our teams also competed in a scavenger hunt and associates completed chemical quizzes, which were developed by the Aldevron Safety Team and Committee. Hosting events during Safe + Sound Week, which is celebrated nationwide to recognize workplace health and safety programs, is another way Aldevron is able to lead as an innovator and ensure we are #advancingeveryday for our patients. We are committed to keeping health and safety at the forefront of everything we do for our teams and clients. #HealthAndSafety #SafeandSoundWeek #Hiring
-
-
Anyone hungry for dessert? 🥧 This week, our managers in the Madison office got a whole pie – in their faces! At our “Pie Your Manager” event, applause and laughs echoed throughout Aldevron as we raised money for the Badger Challenge, an annual cycling, running and walking event that raises funds for vital cancer research at the UW Carbone Cancer Center Cancer Center. It is our third year sponsoring the challenge, and it is always a fun reminder of our purpose to help find cures for cancer and other #rarediseases. We’re happy to share that through this event, we surpassed our $15,000 fundraising goal! We're also raising funds for the Badger Challenge through various activities like hosting bake sales and live auctions, and we look forward to participating in the race. Read more about our event, which was featured in WKOW-ABC 27 News here: https://ald.bio/3XkawWJ #CancerResearch #MadisonWI #BadgerChallenge #UW
Local biotechnology company raises money for Badger Challenge, to advance cancer research
wkow.com
-
Today, we are excited to announce our renewed commitment to Aldevron Advocacy and the launch of a new program focused on “New Frontiers in Cellular Immunotherapies.” As our President Jennifer Meade stated, “Advocacy is about speaking up and acting on behalf of those we seek to support, to ensure their perspectives and challenges are heard, understood, and acted upon.” To achieve these objectives, we are investing additional resources and developing a strategic approach for prioritizing advocacy through this program. As we are inspired by patient stories each day, we look forward to working closely with the Emily Whitehead Foundation, an organization that supports research and clinical trials for childhood cancer treatments, especially #CAR T-cell therapy. Stay tuned for more ways our team is getting involved and driving forward our advocacy, including attending Emily Whitehead Foundation’s Believe Ball this September!
At Aldevron, advocacy is at the center of everything we do. I’m excited to share that we’ve made a renewed commitment to Aldevron Advocacy and are launching a new program with an initial focus on “New Frontiers in Cellular Immunotherapies.” By investing additional resources and developing a focused, strategic direction for advocacy, we’re enhancing our mission of #advancingeveryday and seeking new ways to impact our clients and the patients we serve. I’m especially looking forward to collaborating further with the Emily Whitehead Foundation, an organization that inspires me every day and celebrates the transformative power of innovative therapies. We have a variety of exciting programming on the horizon, offering our team members the opportunity to support and make a difference. Read more in my latest blog post on how we are working every day to create meaningful change: https://lnkd.in/e4d2C9RA. More to come from our team soon!
-
Are you early in your clinical programs? Aldevron’s new small-scale cGMP service for up to 500mg of plasmid DNA deliverables helps you advance your work through our seamless experience. Prepare for pivotal trials knowing your pDNA partner has been providing clients with the highest quality products and services since 1998. Discover how we can help advance your innovations by clicking here. https://ald.bio/4dFz3ez
-
-
Aldevron's Summer Celebration was a hit! We welcomed more thank 850 associates and their families to enjoy some Friday night fun with the Fargo-Moorhead RedHawks Baseball team! #teamaldevron Jennifer Meade AJ Muehlberg Lance Monilaws Michael Jablon Carter Kipp Alicia Schlenner
-
-
ICYMI Keeping impurities out of mRNA therapeutics can be a challenge. In particular, double-stranded RNA (dsRNA) could lead to adverse effects. In his latest blog post, Kyle Studey explains that engineered enzymes may present a solution to dsRNA formation. https://ald.bio/4cFTBlM
-